Skip to content

Integrative bioinformatics, machine learning, and molecular docking identify HigBA toxin-antitoxin systems as key mediators of quorum sensing in Acinetobacter baumannii.

Aug 2026 · Computational biology and chemistry · Vol 125, pp. 109362 · 0 citations · 61 references
Medicine

Abstract

Acinetobacter baumannii is a high-priority pathogen due to its extensive antimicrobial resistance and persistence in clinical environments. Quorum sensing (QS) and toxin-antitoxin (TA) systems regulate virulence and stress tolerance, yet their interconnection remains unclear. We analyzed transcriptomic data (GSE87009) from A. baumannii treated with 3-oxo-C12-HSL using WGCNA, differential expression, and machine learning (LASSO and Random Forest). To identify potential inhibitors of the HigBA TA system, we performed molecular docking of 202 chemically diverse compounds - comprising approved drugs, natural products, and synthetic molecules - against the four HigBA proteins using AutoDock Vina, followed by Protein-Ligand Interaction Profiler (PLIP)-based interaction profiling to validate binding modes. WGCNA identified Module 1 (10 genes) as the primary QS-responsive module (r = -0.996, p = 0.0041), containing two complete HigBA systems (chromosomal and plasmid-borne), proteases, transposases, and a catalase. LASSO and Random Forest converged on the four TA genes as robust QS predictors. Docking identified Ligand 17 as the best binder for HigB2 (-7.65 kcal/mol), followed by Ligand 147 for HigA2 (-6.61 kcal/mol), Ligand 198 for HigB1 (-6.79 kcal/mol), and Ligand 178 for HigA1 (-4.51 kcal/mol). PLIP validation confirmed that all ligands occupy the ATP-binding cleft; Deslanoside (147) forms 23 hydrogen bonds, Meclizine (198) anchors via CYS83, while Promazine (178) and Estradiol (17) rely on hydrophobic contacts. These findings provide a mechanistic link between QS and TA systems, thus providing new therapeutic targets for tackling virulence and persistence.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.